Denali Therapeutics Inc.
USD25.89
+0.32 (+1.25%)
CEO
Ryan J. Watts
IPO Date
2017-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$25.54
Prev. Close
$25.57
Day Low
$25.54
Day High
$26.11
52W Low
$12.58
52W High
$26.19
Market Cap
$4.11B
Volume
2.13M
| -7.9 |
| 31 Dec 2023 | FY | 100.0% | -43.9% | -14.1% | -12.6% | 0.05 | 13.65 | -20.3 |
| 31 Dec 2022 | FY | 100.0% | -300.6% | -31.3% | -22.3% | 0.06 | 3.77 | -10.7 |
| 31 Dec 2021 | FY | 100.0% | -597.2% | -30.2% | -20.7% | 0.07 | 2.37 | -18.7 |
| 31 Dec 2020 | FY | 100.0% | 21.2% | 6.2% | 4.4% | 0.06 | 20.86 | 128.3 |
| 31 Dec 2019 | FY | 100.0% | -740.7% | -50.0% | -35.7% | 0.18 | 9.48 | -8.4 |
| 31 Dec 2018 | FY | 100.0% | -28.1% | -6.6% | -5.5% | 0.00 | 14.67 | -52.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -18.9% | -18.1% | 0.00 | 28.92 | -2.7 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -34.0% | -32.0% | 0.00 | 19.98 | -1.6 |
| -5.6 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -13.7% | -12.0% | 0.05 | 9.79 | -4.9 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -12.1% | -10.6% | 0.05 | 10.27 | -4.8 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -11.8% | -10.5% | 0.04 | 9.56 | -4.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -9.3% | -8.4% | 0.04 | 8.46 | -7.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -8.1% | -7.4% | 0.04 | 9.98 | -11.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -7.1% | -6.6% | 0.04 | 12.46 | -9.4 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -7.0% | -6.4% | 0.03 | 11.79 | -7.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -11.6% | -10.4% | 0.05 | 13.65 | -6.2 |